ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Allurion Technologies Inc

Allurion Technologies Inc (ALUR)

5.52
-0.52
(-8.61%)
終了 2月11日 6:00AM
5.52
0.00
( 0.00% )
プレマーケット: 8:33PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
5.52
買値
-
売値
-
出来高
1,069
0.00 日の範囲 0.00
2.3669 52 週間の範囲 98.75
時価総額
前日終値
5.52
始値
-
時刻
7
@
5.52
最終取引時間
20:03:49
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,858,266
発行済株式数
2,711,263
配当利回り
-
PER
-0.18
1 株当たり利益 (EPS)
-30.36
歳入
53.47M
純利益
-82.3M

Allurion Technologies Inc について

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient ... Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. 詳細を表示

セクター
Blank Checks
業界
Blank Checks
本社
Wilmington, Delaware, USA
設立
-
Allurion Technologies Inc is listed in the Blank Checks sector of the ニューヨーク証券取引所 with ticker ALUR. The last closing price for Allurion Technologies was US$5.52. Over the last year, Allurion Technologies shares have traded in a share price range of US$ 2.3669 to US$ 98.75.

Allurion Technologies currently has 2,711,263 shares in issue. The market capitalisation of Allurion Technologies is US$14.97 million. Allurion Technologies has a price to earnings ratio (PE ratio) of -0.18.

ALUR 最新ニュース

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a definitive securities purchase agreement...

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the...

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received an Issue Notification from the U.S. Patent and...

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a subscription agreement with funds...

Allurion Announces Positive Topline Results From AUDACITY Trial

At 48 weeks, Allurion Balloon subjects had a greater than 50% responder rate and substantially greater weight loss than Control subjects Low rate of serious adverse events supports favorable...

Allurion Technologies, Inc. Announces Reverse Stock Split

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a...

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the Listings Operations Committee of the New York Stock...

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

AllurionMeds is designed to address a critical demand from patients: The Weight Must Stay Off Features Coach Iris, a first-of-its-kind conversational AI behavioral agent for weight loss and...

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced its financial results for the third quarter ended September 30, 2024...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.98-15.07692307696.56.615.321948356.18430718CS
42.3574.13249211363.1716.862.366942229318.37821491CS
12-4.2275-43.37009489619.747516.862.366918582668.67248403CS
26-13.73-71.324675324719.2522.251252.36699240699.48408282CS
52-64.23-92.086021505469.7598.752.3669104953341.06686682CS
156-219.48-97.54666666672252252.366971111443.96924743CS
260-219.48-97.54666666672252252.366971111443.96924743CS

ALUR - Frequently Asked Questions (FAQ)

What is the current Allurion Technologies share price?
The current share price of Allurion Technologies is US$ 5.52
How many Allurion Technologies shares are in issue?
Allurion Technologies has 2,711,263 shares in issue
What is the market cap of Allurion Technologies?
The market capitalisation of Allurion Technologies is USD 14.97M
What is the 1 year trading range for Allurion Technologies share price?
Allurion Technologies has traded in the range of US$ 2.3669 to US$ 98.75 during the past year
What is the PE ratio of Allurion Technologies?
The price to earnings ratio of Allurion Technologies is -0.18
What is the cash to sales ratio of Allurion Technologies?
The cash to sales ratio of Allurion Technologies is 0.28
What is the reporting currency for Allurion Technologies?
Allurion Technologies reports financial results in USD
What is the latest annual turnover for Allurion Technologies?
The latest annual turnover of Allurion Technologies is USD 53.47M
What is the latest annual profit for Allurion Technologies?
The latest annual profit of Allurion Technologies is USD -82.3M
What is the registered address of Allurion Technologies?
The registered address for Allurion Technologies is 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
Which industry sector does Allurion Technologies operate in?
Allurion Technologies operates in the BLANK CHECKS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ETBEaton Vance Tax Managed Buy Write Income Fund
US$ 23.59
(57.79%)
1
ETYEaton Vance Tax Managed Diversified Equity Income Fund
US$ 24.19
(55.76%)
1
LZMLifezone Metals Limited
US$ 8.99
(53.15%)
1
MPVBarings Participation Investors
US$ 25.99
(52.34%)
1
SLQTSelectQuote Inc
US$ 5.90
(34.70%)
387.47k
SDHYPGIM Short Duration High Yield Opportunities Fund
US$ 11.01
(-33.71%)
8
KFKorea Fund Inc
US$ 14.01
(-30.44%)
11
AMTBAmerant Bancorp Inc
US$ 17.01
(-26.68%)
6
GNEGenie Energy Ltd
US$ 11.20
(-22.06%)
10
ZIPZipRecruiter Inc
US$ 6.33
(-21.76%)
4
BBAIBigBear ai Holdings Inc
US$ 8.52
(-2.29%)
749.89k
SLQTSelectQuote Inc
US$ 5.90
(34.70%)
387.47k
ACHRArcher Aviation Inc
US$ 10.05
(-1.47%)
336.36k
JOBYJoby Aviation Inc
US$ 7.88
(0.64%)
272.17k
NIONIO Inc
US$ 4.25
(-1.85%)
252.24k

ALUR Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock